Circulation

Vol. 154, Issue 3 Issue 3 2026
14
Articles

Articles in this Issue

Sirolimus-Eluting Balloon With Provisional Stenting Versus Systematic Drug-Eluting Stent Implantation to Treat De Novo Coronary Lesions: A Randomized, Open-Label, Noninferiority Trial

Christian Spaulding, Florian Krackhardt, Kris Bogaerts et al. Jul 21, 2026 pp. 185-197 10.1161/circulationaha.126.079033

BACKGROUND: Implantation of drug eluting stents (DESs) is currently the default approach for percutaneous coronary interventions, but long-term adverse events still exist. An appro...

Loss of ATP-Dependent Citrate Lyase Drives Left Ventricular Dysfunction by Metabolic Remodeling

Shijie Liu, Seth T. Gammon, Lin Tan et al. Jul 21, 2026 pp. 223-239 10.1161/circulationaha.125.076453

BACKGROUND: Metabolic adaptation and maladaptation are hallmarks of the failing heart and may be a target for therapeutic interventions. For example, sustain...

Ethics of Navigating Organ Scarcity in Heart Transplantation

Ersilia M. DeFilippis, Michelle M. Kittleson Jul 21, 2026 pp. 296-298 10.1161/circulationaha.126.081604

Stent-Free PCI: Have We Found the SELUTION?

Raef A. Fadel, Herbert D. Aronow Jul 21, 2026 pp. 198-200 10.1161/circulationaha.126.080861

Rapid Ultraoxygenated Recovery Without Preimplant Reanimation Using Older Donation After Circulatory Death Heart Donors

Aaron M. Williams, Chen Chia Wang, Kevin C. McGann et al. Jul 21, 2026 pp. 268-270 10.1161/circulationaha.126.079750

From Discovery to Impact in the <i>Circulation</i> Life Cycle

Sadiya S. Khan Jul 21, 2026 pp. 183-184 10.1161/circulationaha.126.080163

Comparative Efficacy of Transfusion Strategies in Women and Men With Myocardial Infarction and Anemia: Prespecified Secondary Findings From the MINT Trial

J. Dawn Abbott, Jocelyne R. Benatar, Colleen M. Ballantyne et al. Jul 21, 2026 pp. 201-211 10.1161/circulationaha.125.078320

BACKGROUND: The optimal transfusion strategy in patients with acute myocardial infarction (AMI) and anemia may be influenced by sex differences in pathophysiology and cardiovascula...

Incremental Prognostic Value of Subendocardial Myocardial Flow Reserve in Patients With Normal Perfusion

Diana M. Lopez, Jenifer M. Brown, Sanjay Divakaran et al. Jul 21, 2026 pp. 212-222 10.1161/circulationaha.125.078816

BACKGROUND: Although the prognostic utility of positron emission tomography (PET) myocardial flow reserve (MFR) is well established, emerging data suggest th...

SIRT5 Ameliorates Cardiac Fibrosis via PCK2 Desuccinylation-Mediated Metabolic Reprogramming in Cardiac Fibroblasts

Maoxiong Wu, Jing Tan, Weibin Zhou et al. Jul 21, 2026 pp. 243-264 10.1161/circulationaha.125.077756

BACKGROUND: SIRT5 (sirtuin 5) is a member of the sirtuin family known to regulate cardiac metabolism, aging, and function. However, its role in cardiac fibroblast (CFB) metabolism,...

Cold Oxygenated Rapid Recovery in Heart Donation After Circulatory Death

Elizabeth J. Bashian, Thomas F. O’Shea, David N. Campbell et al. Jul 21, 2026 pp. 265-267 10.1161/circulationaha.126.079915

Diagnostic Approach to Cardiac Sarcoidosis

Jukka Lehtonen, David H. Birnie Jul 21, 2026 pp. 288-295 10.1161/circulationaha.126.079275

Cardiac sarcoidosis is a granulomatous myocarditis, classified by some authorities as an infiltrative cardiomyopathy and by others as an inflammatory cardiomyopathy, that carries an elevated risk of l...

Cracking the Code of Cardiac ATP-Dependent Citrate Lyase With Wet and Dry Tools

Matthew A. Walker, Rong Tian Jul 21, 2026 pp. 240-242 10.1161/circulationaha.126.081162

Ethical Considerations for Heart Organ Allocation: Current Landscape and Future Policy Guidance: A Scientific Statement From the American Heart Association

Prateeti Khazanie, Mark H. Drazner, Khadijah Breathett et al. Jul 21, 2026 10.1161/cir.0000000000001439

The heart transplant allocation system is evolving in response to increasing demand for donor organs, technological advances, and changes in medical decision-making. In this evolving landscape, the hi...

Does Characterization of Phenotypic Heterogeneity Provide Mechanistic Insights or Influence the Response to Treatment? Experience in Positive and Neutral Trials in Patients With Heart Failure and a Preserved Ejection Fraction

Milton Packer, Gabriele G. Schiattarella, Mark C. Petrie et al. Jul 21, 2026 pp. 271-287 10.1161/circulationaha.126.079235

At a time when there was no unifying hypothesis and no broadly effective treatments for heart failure with a preserved ejection fraction (HFpEF), it was proposed that HFpEF represented a multitude of...

All Issues

Journal Info

Publisher Lippincott Williams & Wilkins
ISSN 0009-7322
E-ISSN 1524-4539
Subject Health Sciences
Language English
View Full Journal Page